Dr. Daniela Hozbor, a biochemist at the National University of La Plata, is spearheading international efforts to enhance pertussis vaccines through rigorous molecular-level research. Her career trajectory—spanning 400 kilometres from her hometown to pursue advanced studies—reflects a commitment to understanding infectious disease mechanisms with direct clinical applications.
Hozbor’s research philosophy bridges a critical gap in vaccine science: translating laboratory discoveries into tangible public health solutions. Working within an international collaborative framework, she investigates molecular interactions between pathogens and vaccine components to identify vulnerabilities in current immunisation strategies. Her approach directly addresses the resurgence of whooping cough, which affects millions globally and claims approximately 160,700 lives annually, particularly among infants under one year old.
Reared in a household that prioritised both scientific inquiry and practical problem-solving, Hozbor’s interdisciplinary perspective has become instrumental in advancing next-generation pertussis prevention strategies. Read the full article on GMJ Newsroom.
Was this article helpful?
